INTERNATIONAL PATENT: SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD, 深圳信立泰药业股份有限公司 FILES APPLICATION FOR "PCSK9 AND HMG-COA DUAL-TARGET COMPOUND AND USE THEREOF"

GENEVA, Feb. 2 -- SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD (Zone A, 4F, 289 Digitland, 2 Hongliu Road, Futian DistrictShenzhen, Guangdong 518017), 深圳信立泰药业股份有限公司 (中国广东省深圳市福田区福保街道福保社区红柳道2号289数字半岛4层A区) filed a patent application (PCT/CN2025/109569) for "PCSK9 AND HMG-COA DUAL-TARGET COMPOUND AND USE THEREOF" on Jul 21, 2025. With publication no. WO/2026/021380, the details related to the patent application was published on Jan 29, 2026.

Notably, the pa...